Home › GSK melanoma drug combination wins accelerated U.S. approval
 

Keywords :   


GSK melanoma drug combination wins accelerated U.S. approval

2014-01-09 20:14:48| Biotech - Topix.net

A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has won accelerated approval from U.S. regulators.

Tags: combination drug approval wins

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »